The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

The Journal of Immunology, 1961, 87: 415-425.
Copyright © 1961 by The American Association of Immunologists, Inc.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eigelsbach, H. T.
Right arrow Articles by Downs, C. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Eigelsbach, H. T.
Right arrow Articles by Downs, C. M.

Prophylactic Effectiveness of Live and Killed Tularemia Vaccines

I. Production of Vaccine and Evaluation in the White Mouse and Guinea Pig

Henry T. Eigelsbach and Cora M. Downs

From the Chemical Corps Biological Laboratories, Fort Detrick, Maryland, and the Department of Bacteriology, University of Kansas, Lawrence Kansas

Abstract

An attenuated USSR vaccine culture of P. tularensis was examined for dissociation and found heterogeneous with regard to colony type morphology. Live BV, the more immunogenic of two variants isolated from the culture, proved effective for the protection of the mouse against s.c. challenge with strain SCHU S4; in contrast, killed cultures were not immunogenic. Guinea pigs vaccinated with live BV cells and challenged with strain SCHU S4 exhibited an appreciably longer survival time than animals vaccinated with killed preparations but eventually they succumbed.

Although SCHU S1-11, one of several colony type variants of reduced virulence isolated from strain SCHU S1, proved equally as immunogenic for the mouse as BV and afforded the guinea pig greater protection than BV, the relatively high residual virulence of this variant for the guinea pig precluded its use as a vaccine strain. Serial animal passage of BV permitted the isolation of a culture that was ultimately selected for the production of live vaccine. The culture was designated the live vaccine strain (LVS) and is currently being used for the production of lyophilized live vaccine for use in man.

Strain SCHU S4 proved superior to strain 503 as a challenge strain for quantitating the protection afforded test animals administered live vaccines.

Data on the immunogenicity and storage stability of lyophilized live tularemia vaccine produced from cells harvested from GCHA and more recently from MCPH proved sufficiently encouraging to have warranted an extension of this study to a systematic evaluation of the vaccine in the monkey and subsequently in man.




This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
J. M. Ketavarapu, A. R. Rodriguez, J.-J. Yu, Y. Cong, A. K. Murthy, T. G. Forsthuber, M. N. Guentzel, K. E. Klose, M. T. Berton, and B. P. Arulanandam
Mast cells inhibit intramacrophage Francisella tularensis replication via contact and secreted products including IL-4
PNAS, July 8, 2008; 105(27): 9313 - 9318.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
S. Chakraborty, M. Monfett, T. M. Maier, J. L. Benach, D. W. Frank, and D. G. Thanassi
Type IV Pili in Francisella tularensis: Roles of pilF and pilT in Fiber Assembly, Host Cell Adherence, and Virulence
Infect. Immun., July 1, 2008; 76(7): 2852 - 2861.
[Abstract] [Full Text] [PDF]

Home page
 J. Bacteriol.Home page
J. S. Ludu, O. M. de Bruin, B. N. Duplantis, C. L. Schmerk, A. Y. Chou, K. L. Elkins, and F. E. Nano
The Francisella Pathogenicity Island Protein PdpD Is Required for Full Virulence and Associates with Homologues of the Type VI Secretion System
J. Bacteriol., July 1, 2008; 190(13): 4584 - 4595.
[Abstract] [Full Text] [PDF]

Home page
 Appl. Environ. Microbiol.Home page
S. A. Rodriguez, J.-J. Yu, G. Davis, B. P. Arulanandam, and K. E. Klose
Targeted Inactivation of Francisella tularensis Genes by Group II Introns
Appl. Envir. Microbiol., May 1, 2008; 74(9): 2619 - 2626.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. C. Cowley, J. D. Sedgwick, and K. L. Elkins
Differential Requirements by CD4+ and CD8+ T Cells for Soluble and Membrane TNF in Control of Francisella tularensis Live Vaccine Strain Intramacrophage Growth
J. Immunol., December 1, 2007; 179(11): 7709 - 7719.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
T. M. Maier, M. S. Casey, R. H. Becker, C. W. Dorsey, E. M. Glass, N. Maltsev, T. C. Zahrt, and D. W. Frank
Identification of Francisella tularensis Himar1-Based Transposon Mutants Defective for Replication in Macrophages
Infect. Immun., November 1, 2007; 75(11): 5376 - 5389.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
K.-J. Hong, J. R. Wickstrum, H.-W. Yeh, and M. J. Parmely
Toll-Like Receptor 2 Controls the Gamma Interferon Response to Francisella tularensis by Mouse Liver Lymphocytes
Infect. Immun., November 1, 2007; 75(11): 5338 - 5345.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
L. E. Cole, K. A. Shirey, E. Barry, A. Santiago, P. Rallabhandi, K. L. Elkins, A. C. Puche, S. M. Michalek, and S. N. Vogel
Toll-Like Receptor 2-Mediated Signaling Requirements for Francisella tularensis Live Vaccine Strain Infection of Murine Macrophages
Infect. Immun., August 1, 2007; 75(8): 4127 - 4137.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
N. P. Mohapatra, S. Soni, B. L. Bell, R. Warren, R. K. Ernst, A. Muszynski, R. W. Carlson, and J. S. Gunn
Identification of an Orphan Response Regulator Required for the Virulence of Francisella spp. and Transcription of Pathogenicity Island Genes
Infect. Immun., July 1, 2007; 75(7): 3305 - 3314.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
J. Su, J. Yang, D. Zhao, T. H. Kawula, J. A. Banas, and J.-R. Zhang
Genome-Wide Identification of Francisella tularensis Virulence Determinants
Infect. Immun., June 1, 2007; 75(6): 3089 - 3101.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
C. RICK LYONS and T. H. WU
Animal Models of Francisella tularensis Infection
Ann. N.Y. Acad. Sci., June 1, 2007; 1105(1): 238 - 265.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
J. WAYNE CONLAN and P. C.F. OYSTON
Vaccines Against Francisella Tularensis
Ann. N.Y. Acad. Sci., June 1, 2007; 1105(1): 325 - 350.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
J. S. GUNN and R. K. ERNST
The Structure and Function of Francisella Lipopolysaccharide
Ann. N.Y. Acad. Sci., June 1, 2007; 1105(1): 202 - 218.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
K. L. ELKINS, S. C. COWLEY, and C. M. BOSIO
Innate and Adaptive Immunity to Francisella
Ann. N.Y. Acad. Sci., June 1, 2007; 1105(1): 284 - 324.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. M. Bosio, H. Bielefeldt-Ohmann, and J. T. Belisle
Active Suppression of the Pulmonary Immune Response by Francisella tularensis Schu4
J. Immunol., April 1, 2007; 178(7): 4538 - 4547.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
N. P. Mohapatra, A. Balagopal, S. Soni, L. S. Schlesinger, and J. S. Gunn
AcpA Is a Francisella Acid Phosphatase That Affects Intramacrophage Survival and Virulence
Infect. Immun., January 1, 2007; 75(1): 390 - 396.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
R. M. Thomas, R. W. Titball, P. C. F. Oyston, K. Griffin, E. Waters, P. G. Hitchen, S. L. Michell, I. D. Grice, J. C. Wilson, and J. L. Prior
The Immunologically Distinct O Antigens from Francisella tularensis Subspecies tularensis and Francisella novicida Are both Virulence Determinants and Protective Antigens
Infect. Immun., January 1, 2007; 75(1): 371 - 378.
[Abstract] [Full Text] [PDF]

Home page
 MicrobiologyHome page
E. D. LoVullo, L. A. Sherrill, L. L. Perez, and M. S. Pavelka Jr
Genetic tools for highly pathogenic Francisella tularensis subsp. tularensis.
Microbiology, November 1, 2006; 152(Pt 11): 3425 - 3435.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
R. Tempel, X.-H. Lai, L. Crosa, B. Kozlowicz, and F. Heffron
Attenuated Francisella novicida Transposon Mutants Protect Mice against Wild-Type Challenge
Infect. Immun., September 1, 2006; 74(9): 5095 - 5105.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
R. Pechous, J. Celli, R. Penoske, S. F. Hayes, D. W. Frank, and T. C. Zahrt
Construction and Characterization of an Attenuated Purine Auxotroph in a Francisella tularensis Live Vaccine Strain.
Infect. Immun., August 1, 2006; 74(8): 4452 - 4461.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
E. B. Nix, K. K. M. Cheung, D. Wang, N. Zhang, R. D. Burke, and F. E. Nano
Virulence of Francisella spp. in Chicken Embryos.
Infect. Immun., August 1, 2006; 74(8): 4809 - 4816.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. E. Cole, K. L. Elkins, S. M. Michalek, N. Qureshi, L. J. Eaton, P. Rallabhandi, N. Cuesta, and S. N. Vogel
Immunologic Consequences of Francisella tularensis Live Vaccine Strain Infection: Role of the Innate Immune Response in Infection and Immunity.
J. Immunol., June 1, 2006; 176(11): 6888 - 6899.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
J. Katz, P. Zhang, M. Martin, S. N. Vogel, and S. M. Michalek
Toll-Like Receptor 2 Is Required for Inflammatory Responses to Francisella tularensis LVS.
Infect. Immun., May 1, 2006; 74(5): 2809 - 2816.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
A. I Duenas, M. Aceves, A. Orduna, R. Diaz, M. Sanchez Crespo, and C. Garcia-Rodriguez
Francisella tularensis LPS induces the production of cytokines in human monocytes and signals via Toll-like receptor 4 with much lower potency than E. coli LPS
Int. Immunol., May 1, 2006; 18(5): 785 - 795.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
M. A. Pammit, E. K. Raulie, C. M. Lauriano, K. E. Klose, and B. P. Arulanandam
Intranasal Vaccination with a Defined Attenuated Francisella novicida Strain Induces Gamma Interferon-Dependent Antibody-Mediated Protection against Tularemia
Infect. Immun., April 1, 2006; 74(4): 2063 - 2071.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
S. C. Cowley and K. L. Elkins
Multiple T Cell Subsets Control Francisella tularensis LVS Intracellular Growth Without Stimulation Through Macrophage Interferon {gamma} Receptors
J. Exp. Med., August 4, 2003; 198(3): 379 - 389.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1961 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1961 by The American Association of Immunologists, Inc. All rights reserved.